Hers vs Remedy Meds
Hers has an open FDA warning letter dated September 9, 2025. Remedy Meds has an open FDA warning letter dated September 9, 2025. On compounded semaglutide injection, Hers costs $1,200 less a year at standing rates: $199 a month against $299 a month at Remedy Meds.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Hers / Remedy Meds
Hers
6.8/10
Remedy Meds
5.6/10
- Apostrophe Pharmacy LLCtype not stated
- XeCare LLCtype not stated
- MedisourceRx503B
Neither Hers nor Remedy Meds pays us. Links to them earn nothing. Scores: Hers 6.8, Remedy Meds 5.6. How we are paid
What the record shows
- 01
Hers has an open FDA warning letter dated September 9, 2025. Remedy Meds has an open FDA warning letter dated September 9, 2025.
- 02
Hers names three pharmacies. Remedy Meds names no compounding pharmacy in our record.
- 03
On compounded semaglutide injection, Hers costs $1,200 less a year at standing rates: $199 a month against $299 a month at Remedy Meds.
- 04
Only Hers lists a price for brand-name tirzepatide pen. Only Remedy Meds lists a price for compounded tirzepatide injection.
- 05
Hers covers one state Remedy Meds does not.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Hers
Remedy Meds
$199/moLower
$2,388 a year
$299/mo
$3,588 a year
$399/mo
$4,788 a year
$299/mo
medication only, membership extra; not compared
Read off each seller’s own pages. Hers: September 28, 2026. Remedy Meds: October 30, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Hers
6.8/10- $1,200 a year less on compounded semaglutide injection
- Sells brand-name tirzepatide pen, which Remedy Meds does not price
- Names its compounding pharmacy
- Open FDA warning letter, September 9, 2025
- Price leaves out clinician visits and coaching
The case for Remedy Meds
5.6/10- Sells compounded tirzepatide injection, which Hers does not price
- Price includes clinician visits
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
Scores
Hers 6.8 · Remedy Meds 5.6 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Hers vs Remedy Meds: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Eden8.7
From $99/mo
Visit site - YourEra9.0
From $99/mo
Visit site - Gala8.5
From $179/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks